Joaquín Botta (Joaquin Botta)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Parkinson Disease

Endothelial Cells

Drug Administration

Tyrosine Kinase

Top Venues

Science (New York, N.Y.)

Life science alliance

This page only lists publications with an associated author ORCID identifier.

Publications

Hadar Israeli, Oksana Degtjarik, Fabrizio Fierro, Vidicha Chunilal, Amandeep Kaur Gill, Nicolas J Roth, Joaquín Botta, Vadivel Prabahar, Yoav Peleg, Li F Chan, Danny Ben-Zvi, Peter J McCormick, Masha Y Niv, Moran Shalev-Benami
Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling. Science (New York, N.Y.) 372 (6544) (2021)
Jack L Williams, Anju Paudyal, Sherine Awad, James Nicholson, Dominika Grzesik, Joaquín Botta, Eirini Meimaridou, Avinaash V Maharaj, Michelle Stewart, Andrew Tinker, Roger D Cox, Louise A Metherell
Mylk3 null C57BL/6N mice develop cardiomyopathy, whereas Nnt null C57BL/6J mice do not. Life science alliance 3 (4) (2020)
David Moreno-Delgado, Mar Puigdellívol, Estefanía Moreno, Mar Rodríguez-Ruiz, Joaquín Botta, Paola Gasperini, Anna Chiarlone, Lesley A Howell, Marco Scarselli, Vicent Casadó, Antoni Cortés, Sergi Ferré, Manuel Guzmán, Carmen Lluís, Jordi Alberch, Enric I Canela, Sílvia Ginés, Peter J McCormick
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease. eLife 9 (2020)